Back to Search
COLLEEN BOSSIE, PHARMD
PHARMD
Pharmacist
NPI: 1952778896Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PR45388(ME)
Research & Publications (20)
Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms.
PMID 19552963·J Affect Disord·2010
2-rct
Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms.
PMID 19560322·Schizophr Res·2009
4-observational
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
PMID 19411369·Am J Psychiatry·2009
2-rct
Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression.
PMID 17928573·Am J Geriatr Psychiatry·2008
4-observational
Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
PMID 18441528·Psychopathology·2008
8-other
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia.
PMID 19183785·Neuropsychiatr Dis Treat·2008
8-other
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
PMID 18545059·Int Clin Psychopharmacol·2008
4-observational
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
PMID 18091190·J Nerv Ment Dis·2007
4-observational
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial.
PMID 17019624·J Autism Dev Disord·2007
4-observational
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD.
PMID 17683634·Child Adolesc Psychiatry Ment Health·2007
8-other
A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
PMID 17335334·J Clin Psychiatry·2007
8-other
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.
PMID 17261186·Ann Gen Psychiatry·2007
8-other
Patient-based and clinician-based support for the remission criteria in schizophrenia.
PMID 17159460·Int Clin Psychopharmacol·2007
3-trial
Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone.
PMID 16687995·Int Clin Psychopharmacol·2006
8-other
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
PMID 17054789·BMC Psychiatry·2006
4-observational
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.
PMID 16965196·J Clin Psychiatry·2006
4-observational
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
PMID 16797162·Schizophr Res·2006
4-observational
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.
PMID 16760927·Neuropsychopharmacology·2006
4-observational
New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
PMID 16648343·Am J Psychiatry·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 53 PARIS ST
NORWAY, ME 04268 - Phone
- (617) 780-7953
Quick Facts
- NPI
- 1952778896
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile